Overview

Gender

male

Barney Saunders brings more than 25 years of experience commercializing both emergent and mature technologies in the life science and clinical research markets. Most recently Dr. Saunders served as Chief Commercial Officer of Microchip Biotechnologies (now IntegenX).

Prior to that, Barney was at Agilent Technologies where as General Manager he led the team that launched the first commercially-available, complete genome arrays for human, rat and mouse and also entered the array CGH (comparative genomic hybridization) market.

Dr. Saunders began his career with Amersham International where he held a variety of commercial positions, of increasing responsibility, in the U.S. and Europe. Barney earned a B.Sc. Hons in Biological Sciences and Ph.D. from Birmingham University, England.